$宝济药业-B(02_老虎社区_美港股上老虎

$宝济药业-B(02659)$ 宝济药业2026年7月连续回购，为2025年以来首次密集操作，打破此前半年无回购记录，标志着公司从“研发驱动”向“研发+资本管理”双轮驱动转型初现端倪

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":586307345163504,"tweetId":"586307345163504","gmtCreate":1784172941634,"gmtModify":1784172944054,"author":{"id":4218363023229180,"idStr":"4218363023229180","authorId":4218363023229180,"authorIdStr":"4218363023229180","name":"电白小白15","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 宝济药业2026年7月连续回购，为2025年以来首次密集操作，打破此前半年无回购记录，标志着公司从“研发驱动”向“研发+资本管理”双轮驱动转型初现端倪</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 宝济药业2026年7月连续回购，为2025年以来首次密集操作，打破此前半年无回购记录，标志着公司从“研发驱动”向“研发+资本管理”双轮驱动转型初现端倪</p></body></html>","text":"$宝济药业-B(02659)$ 宝济药业2026年7月连续回购，为2025年以来首次密集操作，打破此前半年无回购记录，标志着公司从“研发驱动”向“研发+资本管理”双轮驱动转型初现端倪","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/586307345163504","repostId":0,"isVote":1,"tweetType":1,"viewCount":222,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02659"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":152,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}